InnoCan Pharma (TSE:INNO) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
InnoCan Pharma celebrates the inclusion of its Scientific Advisory Board member, Dr. Joseph Pergolizzi, in Stanford University’s list of the top 2% most-cited scientists. His influential work in medical science and role in supporting InnoCan’s pharmaceutical R&D and FDA filings highlight his contribution to the company’s innovative healthcare solutions.
For further insights into TSE:INNO stock, check out TipRanks’ Stock Analysis page.